Search

Your search keyword '"Ortega, Gemma"' showing total 282 results

Search Constraints

Start Over You searched for: Author "Ortega, Gemma" Remove constraint Author: "Ortega, Gemma"
282 results on '"Ortega, Gemma"'

Search Results

1. Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial

2. Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum

3. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

4. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

5. New insights into the genetic etiology of Alzheimer’s disease and related dementias

6. Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort

7. Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort

8. FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants

9. Cognitive improvement following endovascular embolization in patients with intracranial dural arteriovenous fistula: The Neuropsychology in dural ArterIal Fistula (NAIF) Study

10. Predementia Counseling

11. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

12. Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

13. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis

14. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

15. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

16. Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

17. FACEmemory®, an innovative online platform for episodic memory pre-screening: findings from the first 3,000 participants

18. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease

19. Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic

20. Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

21. Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort

23. Visual impairment in aging and cognitive decline: experience in a Memory Clinic

25. The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment

26. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

27. Predementia Counseling

29. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients

30. Abstract WP21: Cognitive Improvement In Patients With Dural Arterio-venous Fistula After Endovascular Embolization: Interim Analysis Of The NAIF Study

31. Aplicacions especials dels materials compostos amb fibres vegetals

33. Aplicacions especials dels materials compostos amb fibres vegetals

34. Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment

35. Metabolic syndrome impact on cognitive composites domain scores and on white matter hyperintensities in subjective cognitive decline: The FACEHBI Cohort

36. Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registry.

39. From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery

40. Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects Study Protocol of the PreDADQoL Project

41. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

42. Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

43. Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

44. Interaction of neuropsychiatric symptoms with APOE e4 and conversion to dementia in MCI patients in a memory clinic

48. Caracteristics of a Prospective Cohort of Patients with IPAF (Interstitial Pneumonia with Autoimmune Features) by Neumologists and Reumatologists of Madrid. IPAF-NEREM Study

50. Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy.

Catalog

Books, media, physical & digital resources